0001214659-21-002803.txt : 20210305
0001214659-21-002803.hdr.sgml : 20210305
20210305165019
ACCESSION NUMBER: 0001214659-21-002803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210303
FILED AS OF DATE: 20210305
DATE AS OF CHANGE: 20210305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAGUSA ROBERT P
CENTRAL INDEX KEY: 0001222644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 21719169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-51731.xml
PRIMARY DOCUMENT
X0306
4
2021-03-03
0001581280
Twist Bioscience Corp
TWST
0001222644
RAGUSA ROBERT P
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Common Stock
2021-03-03
4
M
false
10588
30.41
A
12486
D
Common Stock
2021-03-03
4
S
false
2299
132.1549
D
10187
D
Common Stock
2021-03-03
4
S
false
6519
133.0980
D
3668
D
Common Stock
2021-03-03
4
S
false
1770
134.0424
D
1898
D
Director Stock Option (right to buy)
30.41
2021-03-03
4
M
false
10588
0
D
2029-07-22
Common Stock
10588
0
D
Represents the weighted average sales price per share. The shares sold at prices ranging from $131.44 to $132.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $132.59 to $133.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $133.61 to $134.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
100% of the shares subject to the option vested and became exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Robert Ragusa
2021-03-05